Lincoln Pharmaceuticals Limited Stock price NSE India S.E.

Equities

LINCOLN

INE405C01035

Pharmaceuticals

Market Closed - NSE India S.E. 08:02:00 2024-03-28 am EDT 5-day change 1st Jan Change
586 INR -1.20% Intraday chart for Lincoln Pharmaceuticals Limited -2.87% -3.85%
Sales 2022 4.72B 56.65M Sales 2023 5.1B 61.24M Capitalization 6.78B 81.41M
Net income 2022 694M 8.33M Net income 2023 729M 8.75M EV / Sales 2022 1.08 x
Net cash position 2022 1.14B 13.63M Net cash position 2023 1.12B 13.42M EV / Sales 2023 1.11 x
P/E ratio 2022
8.98 x
P/E ratio 2023
9.31 x
Employees 1,645
Yield 2022
0.48%
Yield 2023
0.44%
Free-Float 42.29%
More Fundamentals * Assessed data
Dynamic Chart
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer CI
Lincoln Pharmaceuticals Limited Approves Appointment of Anand A. Patel as an Additional and Whole Time Director CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Lincoln Pharmaceuticals Limited Announces Resignation of Niren A. Desai as Company Secretary / Compliance Officer, with Effect from July 19, 2022 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
More news
1 day-1.20%
1 week-2.87%
Current month-14.50%
1 month-17.64%
3 months-5.38%
6 months+15.72%
Current year-3.85%
More quotes
1 week
582.10
Extreme 582.1
614.95
1 month
555.00
Extreme 555
696.60
Current year
555.00
Extreme 555
755.15
1 year
329.55
Extreme 329.55
755.15
3 years
220.05
Extreme 220.05
755.15
5 years
85.05
Extreme 85.05
755.15
10 years
85.05
Extreme 85.05
755.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 95-01-19
Director of Finance/CFO - 19-03-27
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 70 95-01-19
Chairman 80 95-08-15
Director/Board Member 66 95-01-19
More insiders
Date Price Change Volume
24-03-28 586 -1.20% 39 144
24-03-27 593.2 -2.12% 48,625
24-03-26 606 +0.70% 42,638
24-03-22 601.8 -1.42% 30,853
24-03-21 610.4 +1.18% 53,969

Delayed Quote NSE India S.E., March 28, 2024 at 08:02 am EDT

More quotes
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceuticals products like medicines, injections and other related products. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid in bott, liquid injection and pharma products. It has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The Company's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.
More about the company
  1. Stock
  2. Equities
  3. Stock Lincoln Pharmaceuticals Limited
  4. Stock Lincoln Pharmaceuticals Limited - NSE India S.E.